Haihua Fu

632 total citations
7 papers, 79 citations indexed

About

Haihua Fu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haihua Fu has authored 7 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haihua Fu's work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer Research and Treatments (2 papers) and Cancer Cells and Metastasis (2 papers). Haihua Fu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Cancer Research and Treatments (2 papers) and Cancer Cells and Metastasis (2 papers). Haihua Fu collaborates with scholars based in China and United States. Haihua Fu's co-authors include Xinying Su, Paul R. Gavine, Xiaolu Yin, Shuqiong Fan, Meizhuo Zhang, Tianwei Zhang, Yi Gu, Qiang Liu, Peng Ye and Yanying Shen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Haihua Fu

7 papers receiving 79 citations

Peers

Haihua Fu

ONCOL

MB

PRM

CR

PFM

Xinjun Liang China

Nathalie Trufflandier France

Yuanchuang Li China

Yaelle Tuvy United States

Patricia Iranzo Spain

Xuya Cui China

Sanne Bootsma Netherlands

Mengxue Pan China

Valentina Zanuso Italy

Andrea Garofoli Switzerland

Xinjun Liang China

Haihua Fu

36 ×0.9

ONCOL

39 ×1.1

MB

21 ×0.7

PRM

18 ×0.7

CR

8 ×0.7

PFM

Citations per year, relative to Haihua Fu Haihua Fu (= 1×) peers Xinjun Liang

Countries citing papers authored by Haihua Fu

Since Specialization

Citations

This map shows the geographic impact of Haihua Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haihua Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haihua Fu more than expected).

Fields of papers citing papers by Haihua Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haihua Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haihua Fu. The network helps show where Haihua Fu may publish in the future.

Co-authorship network of co-authors of Haihua Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Haihua Fu. A scholar is included among the top collaborators of Haihua Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haihua Fu. Haihua Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Xu, Yan, Minjiang Chen, Jing Zhao, et al.. (2018). Tumor CD47 expression and a high M2/M1 ratio of tumor-associated macrophages as an adverse prognostic factor in resected stage Ⅲa non-small cell lung cancer.. Journal of Clinical Oncology. 36(15_suppl). e20531–e20531. 2 indexed citations

2.

Cui, Shaohua, Xinying Su, Lili Dong, et al.. (2017). Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer. Journal of Cancer. 8(19). 4075–4082. 7 indexed citations

3.

Jiang, Liyan, Xinying Su, Tianwei Zhang, et al.. (2016). Abstract 5140: PD-L1 expression and its relationship with other driver genes in non-small cell lung cancer (NSCLC). Cancer Research. 76(14_Supplement). 5140–5140. 1 indexed citations

4.

Ye, Peng, Meizhuo Zhang, Shuqiong Fan, et al.. (2015). Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis. PLoS ONE. 10(11). e0143207–e0143207. 26 indexed citations

5.

Yin, Xiaolu, Tianwei Zhang, Xinying Su, et al.. (2015). Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients. PLoS ONE. 10(12). e0143468–e0143468. 16 indexed citations

6.

Zhang, Tianwei, Lin Zhang, Shuqiong Fan, et al.. (2015). Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity. PLoS ONE. 10(7). e0134493–e0134493. 25 indexed citations

7.

Gavine, Paul R., Shiming Fan, Haihua Fu, et al.. (2013). Abstract 928: Volitinib (HMPL504), a novel, selective and potent cMET inhibitor, is efficacious in primary tumor models of cMET-driven gastric cancer.. Cancer Research. 73(8_Supplement). 928–928. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact